When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Acceleron's sotatercept successful in mid-stage PAH study
Acceleron Pharma Inc.
Acceleron Pharma (XLRN-5.5%) announces positive results from a Phase 2 clinical trial, PULSAR, evaluating sotatercept in pulmonary arterial hypertension (PAH) patients. The data were presented virtually at the American Thoracic Society Conference.
More news on: Acceleron Pharma Inc., Healthcare stocks news, Stocks on the move,